Allegati: rep. 11_25 - Gilead Sciences srl.pdf (452.43 KB)rep. 12_25 -ELI LILLY ITALIA SPA.pdf (451.7 KB)rep. 13_25 - DAIICHI SANKYO ITALIA SPA.pdf (452.48 KB)rep. 14_25 - BIOGEN ITALIA SRL.pdf (451.96 KB)rep. 24 _25 -PFIZER SRL.pdf (446.58 KB)REP. 29_25 - ABBVIE srl.pdf (429.33 KB)rep. 30_25 -ELI LILLY Italia spa.pdf (448.21 KB)rep. 31_25 -NOVARTIS FARMA SPA.pdf (456.52 KB)rep. 32_25 -Sanofi spa.pdf (452.39 KB)rep. 33_25 - JANSSEN-CILAG spa.pdf (451.49 KB)rep. 34_25 -BIOVIIX srl.pdf (450.08 KB)rep. 41_25 -OTSUKA PHARMACEUTICAL ITALY SRL (1).pdf (454.05 KB)rep. 114_25 - GLAXOSMITHKLINE SPA.pdf (454.66 KB)rep. 150_25 -BIOGEN ITALIA SRL (1).pdf (450.6 KB)rep. 221_25 -Novo Nordisk spa.pdf (449.59 KB)rep. 246_25 -Novartis Farma spa.pdf (464.14 KB)rep. 222_25 -Sanofi srl.pdf (447.73 KB)rep. 246_25 -Novartis Farma spa.pdf (464.14 KB)rep. 276_25 -Incyte Biosciences Italy SRL.pdf (467.1 KB)rep. 278_25 - Euromed Pharma srl.pdf (465.1 KB)rep. 279_25 - PFIZER srl.pdf (466.79 KB)rep. 280_25 - IPSEN spa.pdf (460.68 KB)rep. 281_25 - TAKEDA italia spa.pdf (467.12 KB)rep. 289_25 - MENARINI STEMLINE ITALIA SRL.pdf (463.74 KB)rep. 290_25 - UCB PHARMA SPA.pdf (465.59 KB)
